Aquamin® ( DrugBank: - )

---

1 disease

ID	Disease name (Link within this page)	Number of trials
97	Ulcerative colitis	2

97. Ulcerative colitis

---

Clinical trials : 2,527 /  Drugs : 1,465 - (DrugBank : 259) / Drug target genes : 144 - Drug target pathways : 202

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04855799 (ClinicalTrials.gov)	November 2, 2021	20/4/2021	GI Permeability Change in Response to Aquamin®	Direct Measurement of Gastrointestinal Permeability Change in Response to Aquamin®	Ulcerative Colitis;Healthy;Irritable Bowel Syndrome With Diarrhea	Drug: Aquamin	James Varani	NULL	Recruiting	18 Years	80 Years	All	30	Phase 2	United States
2	NCT03869905 (ClinicalTrials.gov)	August 8, 2019	8/3/2019	Aquamin® as an Adjuvant Intervention for Ulcerative Colitis	Aquamin®, a Multi-mineral Natural Product From Red Marine Algae, as an Adjuvant Intervention for Mild Ulcerative Colitis and Ulcerative Colitis in Remission	Ulcerative Colitis	Drug: Aquamin®;Drug: Placebo first then Aquamin®	James Varani	NULL	Recruiting	18 Years	80 Years	All	40	Phase 2	United States